Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

De-escalation of Antifungal Treatment in Immunocompromised Critically Ill Patients With Suspected Invasive Candida Infection: Incidence, Associated Factors, and Safety

NCT03774316 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT03774316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03774316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
De-escalation of Antifungal Treatment in Immunocompromised Critically Ill Patients With Suspected Invasive Candida Infection: Incidence, Associated Factors, and Safety
Lead sponsor
University Hospital, Lille
Phase
Observational
Overall status
Completed
Start date
January 28, 2019
Completion date
November 7, 2023
Enrollment
275 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness, invasive fungal disease